The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials

J. S. Kirby; L. Thorlacius; B. Villumsen; J. R. Ingram; A. Garg; K. B. Christensen; M. Butt; S. Esmann; J. Tan; G. B.E. Jemec

doi:10.1111/bjd.18692

The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials

J. S. Kirby
, L. Thorlacius
, B. Villumsen
, J. R. Ingram
, A. Garg
, K. B. Christensen
, M. Butt
, S. Esmann
, J. Tan
, G. B.E. Jemec

Research output: Contribution to journal › Article › peer-review

97 Scopus citations

Abstract

Background: Hidradenitis suppurativa (HS) is a chronic, inflammatory condition that can have a large negative impact on health-related quality of life (HRQOL). A reliable and validated measure of HS-specific HRQOL in clinical studies is needed.

Original language	English (US)
Pages (from-to)	340-348
Number of pages	9
Journal	British Journal of Dermatology
Volume	183
Issue number	2
DOIs	https://doi.org/10.1111/bjd.18692
State	Published - Aug 1 2020

All Science Journal Classification (ASJC) codes

Dermatology

Access to Document

10.1111/bjd.18692

Cite this

@article{4dbaae40f7d34c2fba4a6190340b46cc,

title = "The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials",

abstract = "Background: Hidradenitis suppurativa (HS) is a chronic, inflammatory condition that can have a large negative impact on health-related quality of life (HRQOL). A reliable and validated measure of HS-specific HRQOL in clinical studies is needed.",

author = "Kirby, \{J. S.\} and L. Thorlacius and B. Villumsen and Ingram, \{J. R.\} and A. Garg and Christensen, \{K. B.\} and M. Butt and S. Esmann and J. Tan and Jemec, \{G. B.E.\}",

note = "Publisher Copyright: {\textcopyright} 2019 British Association of Dermatologists",

year = "2020",

month = aug,

day = "1",

doi = "10.1111/bjd.18692",

language = "English (US)",

volume = "183",

pages = "340--348",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - The Hidradenitis Suppurativa Quality of Life (HiSQOL) score

T2 - development and validation of a measure for clinical trials

AU - Kirby, J. S.

AU - Thorlacius, L.

AU - Villumsen, B.

AU - Ingram, J. R.

AU - Garg, A.

AU - Christensen, K. B.

AU - Butt, M.

AU - Esmann, S.

AU - Tan, J.

AU - Jemec, G. B.E.

PY - 2020/8/1

Y1 - 2020/8/1

N2 - Background: Hidradenitis suppurativa (HS) is a chronic, inflammatory condition that can have a large negative impact on health-related quality of life (HRQOL). A reliable and validated measure of HS-specific HRQOL in clinical studies is needed.

AB - Background: Hidradenitis suppurativa (HS) is a chronic, inflammatory condition that can have a large negative impact on health-related quality of life (HRQOL). A reliable and validated measure of HS-specific HRQOL in clinical studies is needed.

UR - https://www.scopus.com/pages/publications/85077214956

UR - https://www.scopus.com/pages/publications/85077214956#tab=citedBy

U2 - 10.1111/bjd.18692

DO - 10.1111/bjd.18692

M3 - Article

C2 - 31705538

AN - SCOPUS:85077214956

SN - 0007-0963

VL - 183

SP - 340

EP - 348

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 2

ER -

The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this